SKB264 Innovative Cancer Antibody Drug Conjugate Clinical Trials Efficacy Insight
September 19, 2024 07:34 ET
|
KuicK Research
Delhi, Sept. 19, 2024 (GLOBE NEWSWIRE) -- SKB264, also known as MK-2870, is an innovative antibody-drug conjugate (ADC) targeting TROP2, currently being developed by Kelun Biotech in partnership...
Bispecific Antibody Drug Conjugates Clinical Trials Insight
September 17, 2024 07:14 ET
|
KuicK Research
Delhi, Sept. 17, 2024 (GLOBE NEWSWIRE) -- The global market for bispecific antibody-drug conjugates (BsADCs) has experienced remarkable expansion, attributed to their revolutionary capabilities in...
Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Commercial Launch Market Forecast 2029
September 12, 2024 07:49 ET
|
KuicK Research
Delhi, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals & Future Market Opportunity Outlook 2029 Report: Report Answers...
Bispecific Antibody Drug Conjugates Mechanism of Action In Cancer Therapy
September 09, 2024 23:00 ET
|
KuicK Research
Delhi, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials Patents Commercial Opportunity Insight Report Highlights: Report Answers Question On Why There...
Clinical Trials In Turkey
September 09, 2024 14:35 ET
|
KuicK Research
Delhi, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Turkey Cancer Drugs Clinical Trials Insight 2024 Report Offering: Turkey Clinical Trials Market Opportunity 2024 and 2030 (In US$ Million)Clinical Trials...
Clinical Trials In Brazil
September 09, 2024 14:21 ET
|
KuicK Research
Delhi, Sept. 09, 2024 (GLOBE NEWSWIRE) -- Brazil Cancer Drugs Clinical Trials Insight 2024 Report Offering: Brazil Clinical Trials Market Opportunity 2024 and 2030 (In US$ Billion)Clinical Trials...
Global Bispecific Antibody Drug Conjugates Bispecific ADC Clinical Trials Commercial Opportunity Insight
September 06, 2024 01:45 ET
|
KuicK Research
Delhi, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials Patents Commercial Opportunity Insight Report Highlights: Report Answers Question On Why There...
CD47 Inhibitor Drug Antibody Clinical Trials Market Size Insight
September 04, 2024 08:00 ET
|
KuicK Research
Delhi, Sept. 04, 2024 (GLOBE NEWSWIRE) -- Global CD47 Inhibitor Drug Clinical Trials Insight and Market Opportunity Outlook 2028 Report Highlights Global and Regional Market Opportunity...
Bispecific Trispecific Tetraspecific Multispecific Antibodies Market Size Clinical Trials Approved Antibody Sales Price Insight Antibodies Market By Region Indication Companies
August 28, 2024 13:24 ET
|
KuicK Research
Delhi, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Global Multispecific Antibodies Market, Drug Sales, Price and Clinical Trials Insight 2029 Report Highlights: Global and Regional Market AnalysisGlobal...
Bispecific Antibodies Market Size By Country Indication Approved Antibodies Sales Bispecific Antibodies Clinical Trials By Phase Companies Indication
August 28, 2024 02:45 ET
|
KuicK Research
Delhi, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market, Drugs Sales, Patent, Price and Clinical Trials Insight 2029 Report Highlights: Bispecific Antibodies Development...